CELH
Celsius Holdings, Inc.
CELH has slightly lower modeled downside risk, despite its lower overall score.
FRPT
Freshpet, Inc.
FRPT has a slight edge over CELH overall on the model score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
FRPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
FRPT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over FRPT in the historical PE scenario, which offers more potential upside but is not a forecast.
FRPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $55.74 | -14% |
| Current | 25x | $64.63 | — |
| Forward | 35x | $64.63 | — |
| Fair | 155x | $402 | +523% |
| Expensive | 1,025x | $2,655 | +4008% |
Historical ranges are pointers, not guarantees.
FRPT's PE is in its cheap range at 25x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 35x, in its fair range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over FRPT on the outlook, with more favorable valuation expectations.
FRPT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FRPT, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
FRPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.83 | -29% |
| Q3 2026 | $2.59 | +14% |
| Q2 2026 | $3.87 | +486% |
| Q1 2026 | $3.81 | +1170% |
| Q4 2025 | $2.64 | +184% |
| Q3 2025 | $2.28 | +153% |
| Q2 2025 | $0.66 | +29% |
| Q1 2025 | $0.30 | +58% |
| Q4 2024 | $0.93 | +$1.63 |
FRPT has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over FRPT on profitability, with a higher operating margin.
FRPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $317.8M | +10% |
| Q2 2026 | $305.6M | +15% |
| Q1 2026 | $297.6M | +13% |
| Q4 2025 | $285.2M | +8.6% |
| Q3 2025 | $288.8M | +14% |
| Q2 2025 | $264.7M | +13% |
| Q1 2025 | $263.2M | +18% |
| Q4 2024 | $262.7M | +22% |
FRPT's revenue has grown year over year every quarter since late 2020: $318M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +2.4 points |
| Q2 2026 | 7.1% | +0.4 points |
| Q1 2026 | 1.5% | +5.8 points |
| Q4 2025 | 16% | +8.2 points |
| Q3 2025 | 8.6% | +3.9 points |
| Q2 2025 | 6.7% | +7.5 points |
| Q1 2025 | -4.4% | -8.2 points |
| Q4 2024 | 7.4% | +0.5 points |
FRPT's operating margin was 11% last quarter, up 2.4 points from the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
FRPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.8M | +20% |
| Q2 2026 | $14.7M | +3203% |
| Q1 2026 | $12.7M | +$34.4M |
| Q4 2025 | $2.1M | +$10M |
| Q3 2025 | $31.6M | +43% |
| Q2 2025 | $445K | +$6.4M |
| Q1 2025 | -$21.7M | +$19.4M |
| Q4 2024 | -$7.9M | +$32.6M |
FRPT has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
FRPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -1.1M shares |
| 1 year | -2% | -1.1M shares |
| 3 years | +14% | +6.5M shares |
| 5 years | +32% | +13.1M shares |
| Available history | +52% | +18.8M shares |
FRPT has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $47.9M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
FRPT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.1x | Net Cash |
| Q1 2025 | -2.6x | Net Cash |
| Q4 2024 | -2.5x | Net Cash |
FRPT has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
FRPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 45.0 | Neutral |
FRPT's weekly RSI is 52 (neutral) and its Stochastic is 45 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
FRPT PE vs Consumer Defensive Sector
| Metric | FRPT | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 19x | 28% above |
| PE % | 22 | 18 | 4 pts above |
FRPT has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
FRPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.7 | 1.5% above |
| 20 week MA | $63.7 | 1.5% above |
| 50 week MA | $63.5 | 1.7% above |
| 100 week MA | $73.7 | 12% below |
| 200 week MA | $84.4 | 23% below |
FRPT has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
FRPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.0 | $143.3 | +143% |
| 2021 | $143.3 | $93.1 | -35% |
| 2022 | $93.1 | $51.5 | -45% |
| 2023 | $51.5 | $86.8 | +68% |
| 2024 | $86.8 | $146.4 | +69% |
| 2025 | $146.4 | $64.2 | -56% |
| 2026 YTD | $64.2 | $64.6 | +0.7% |
FRPT has the edge over CELH on returns for 2026, with the stronger performance.